Medline (MDLN) Enterprise Value (2024 - 2026)

Medline (MDLN) has 3 years of Enterprise Value data on file, last reported at $5.8 billion in Q1 2026.

• Quarterly Enterprise Value changed N/A year-over-year to $5.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.8 billion (changed N/A YoY) and the FY2025 annual result came in at $6.6 billion, up 3421.61% from the prior year.
• Enterprise Value slipped to $5.8 billion in Q1 2026 per MDLN's latest filing, from $6.6 billion in the prior quarter.
• Across five years, Enterprise Value topped out at $6.6 billion in Q4 2025 and bottomed at -$199.0 million in Q4 2024.
• The 3-year median for Enterprise Value is $5.8 billion (2026), against an average of $4.1 billion.
• Peak annual rise in Enterprise Value reached 3421.61% in 2025, while the deepest fall reached 3421.61% in 2025.
• Tracing MDLN's Enterprise Value over 3 years: stood at -$199.0 million in 2024, then surged by 3421.61% to $6.6 billion in 2025, then dropped by 11.63% to $5.8 billion in 2026.
• Per Business Quant, the three latest MDLN Enterprise Value figures stand at $5.8 billion (Q1 2026), $6.6 billion (Q4 2025), and -$199.0 million (Q4 2024).

Peer Comparison